Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRASH Trial: Tranexamic Acid in Hind and Midfoot Arthrodesis Surgery
2026-526142-27-01Phase 3Authorised
- Sponsor
- Helsinki University Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in Foot deformities and osteoarthritis (OA) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Composite surgical site infection rate up to 1 year. Planned start May 2026; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
Foot deformitiesosteoarthritis (OA)
Beyond the preview
Go deeper on 2026-526142-27-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526142-27-01.